Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial-Reference-Cited by-同舟云学术

Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial

Published:2023-08 Issue:10403 Volume:402 Page:693-704
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Aroda Vanita R,Aberle Jens,Bardtrum Lars,Christiansen Erik,Knop Filip K,Gabery Sanaz,Pedersen Sue D,Buse John B

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. 6. Glycemic targets: standards of care in diabetes—2023;ElSayed;Diabetes Care,2023

2. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Davies;Diabetes Care,2022

3. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes—2023;ElSayed;Diabetes Care,2023

4. PIONEER 1: randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes;Aroda;Diabetes Care,2019

5. Oral semaglutide versus empagliflozin in patients with type 2 diabetes uncontrolled on metformin: the PIONEER 2 trial;Rodbard;Diabetes Care,2019

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future is Brighter: New Potential Paradigm-Shifting Medications and Regimens for Diabetes and Obesity;Current Diabetes Reviews;2024-10

2. Analysis of drug–drug interactions in patients with HIV and metabolic syndrome;Expert Opinion on Drug Metabolism & Toxicology;2024-09-10

3. Semaglutide use in people with obesity and type 2 diabetes from real‐world utilization data: An analysis of the All of US Program;Diabetes, Obesity and Metabolism;2024-09-09

4. Clinical efficacy landscaping in genetic obesity: A meta-analysis in Prader Willi syndrome (PWS);2024-08-05

5. Evaluating the safety profile of semaglutide: an updated meta-analysis;Current Medical Research and Opinion;2024-07-27